Mycoplasma pneumoniae pneumonia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Age 1-16 years old, male or female ; 2 Patients who met the diagnostic criteria of Mycoplasma pneumoniae pneumonia in Western medicine and hospitalized children with TCM syndrome differentiation criteria ; 3 children with normal blood routine, total white blood cell count of ( 4.0-12.0 ) × 109 / L, neutrophil ratio of 50 % -75 %, or patients who were judged by researchers not to need antimicrobial therapy ; 4 The guardians of the selected children voluntarily signed the informed consent form, and the children aged = 8 years old needed to voluntarily sign the informed consent form. No serious heart, brain, kidney damage and circulatory, nervous system damage.
Exclusion criteria
Exclusion criteria: 1 The researchers determined that the patients with bacterial and viral infections had white blood cells = 13 × 109 / L, mainly neutrophils or positive respiratory virus nucleic acid test. 2 patients who were known to be allergic to the therapeutic drugs in the research program ; children with continuous use of azithromycin, erythromycin, minocycline, doxycycline, levofloxacin, moxifloxacin and other macrolides or ketolactones, prednisone, methylprednisolone and other glucocorticoid drugs, gamma globulin ( IVIG ) in the first 3 days before enrollment ; 3. 4 children with continuous use of Chinese patent medicines and decoction pieces with heat-clearing and detoxifying, cough-relieving and phlegm-expelling effects within 3 days before enrollment ; 5 life-threatening complications, such as empyema, pneumothorax, lung abscess, necrotizing pneumonia, acute respiratory failure and other serious intrapulmonary complications, or septic shock, viral encephalopathy, and persistent lesions and other serious extrapulmonary complications ; 6 diseases that need to be identified with MPP, such as pulmonary tuberculosis and other uncommon fungal pathogens such as microbial pneumonia ; 7.Pulmonary infection secondary to primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory malformation, pulmonary dysplasia, aspiration pneumonia, pulmonary malignant tumor and other basic diseases ; 8 poor compliance, unable to cooperate with treatment, follow-up or fill in the study records of children.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease efficacy;Number of days of complete cooling;3-day fever reduction rate;7-day fever reduction rate;lung image;Main symptoms curative effect;traditional chinese medicine syndrome;Symptom recurrence rate;etiology detection;laboratory index;serological indicators; | — |
Countries
China
Contacts
the First Affiliated Hospital of Henan University of Traditional Chinese Medicine